Prolonged persistence of mutagenic DNA lesions in stem cells
Peter J. Campbell(Wellcome Sanger Institute), Tim Coorens(Broad Institute), C. Matthias Wilk(Icahn School of Medicine at Mount Sinai), Kenichi Yoshida(Wellcome Sanger Institute), Iñigo Martincorena(Wellcome Sanger Institute), George S. Vassiliou(Wellcome/MRC Cambridge Stem Cell Institute), Anna Maria Ranzoni(Wellcome/MRC Cambridge Stem Cell Institute), Emily Mitchell(Wellcome/MRC Cambridge Stem Cell Institute), Ana Cvejic(University of Copenhagen), Philip S. Robinson(Wellcome Sanger Institute), Kourosh Saeb‐Parsy(University of Cambridge), Kate H.C. Gowers(University College London), Anthony R. Green(Wellcome/MRC Cambridge Stem Cell Institute), Matthew Hoare(University of Cambridge), Margarete A. Fabre(University of Cambridge), Michael R. Stratton(Wellcome Sanger Institute), Steffen Boettcher(University Hospital of Zurich), Sam M. Janes(University College London), Nicholas Williams(Wellcome Sanger Institute), Elisa Laurenti(Wellcome/MRC Cambridge Stem Cell Institute), Jyoti Nangalia(Wellcome Sanger Institute), Krishna Mahbubani(University of Cambridge), Michael Spencer Chapman(Wellcome Sanger Institute), Stanley Ng(University of Toronto), Markus G. Manz(Ospedale San Giovanni Bellinzona)
Cited by 5
Related Papers
COSMIC: the Catalogue Of Somatic Mutations In Cancer
|Nucleic Acids Research|2018|5.2k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
The cancer genome
|Nature|2009|3.5k
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
|The Lancet|2005|3.4k